synthetic peptide-based erythropoiesis stimulating agent
information and resources from the National Cancer Institute
synthetic peptide-based erythropoiesis stimulating agent
A synthetic, non-recombinant, pegylated, peptidic erythropoiesis stimulating agent. Synthetic peptide-based erythropoiesis stimulating agent binds to and activates the erythropoietin (EPO) receptor on erythroid progenitor cells, thereby inducing their proliferation and differentiation into mature erythrocytes. synthetic peptide-based erythropoiesis stimulating agent
A synthetic, non-recombinant, pegylated, peptidic erythropoiesis stimulating agent. Synthetic peptide-based erythropoiesis stimulating agent binds to and activates the erythropoietin (EPO) receptor on erythroid progenitor cells, thereby inducing their proliferation and differentiation into mature erythrocytes.
|
|
|
|
news articles
Hematide(TM) Shown in Phase 2 Trial to Stimulate Red Blood Cell ... Dec 12, 2005
PR Newswire (press release), ...may be more sensitive to Hematide than healthy volunteers." About Hematide(TM) Hematide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), has ...
Hematide Shown in Phase 2 Trial to Stimulate Red Blood Cell ... Dec 12, 2005
PharmaLive.com (press release), Hematide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), has a completely novel amino acid sequence that is unrelated to erythropoietin, a ...
Affymax Announces Results of Hematide Phase 2 Trial to be ... Dec 5, 2005
PharmaLive.com (press release), The poster presentation (ASH abstract #3532), entitled "Hematide, a Synthetic Peptide-Based Erythropoiesis-Stimulating Agent (ESA), Demonstrates Erythropoietic ...
Hematide(TM) Shown in Phase 2 Trial to Stimulate Red Blood Cell ... Dec 12, 2005
PR Newswire (press release), ...may be more sensitive to Hematide than healthy volunteers." About Hematide(TM) Hematide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), has ...
Hematide Shown in Phase 2 Trial to Stimulate Red Blood Cell ... Dec 12, 2005
PharmaLive.com (press release), Hematide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), has a completely novel amino acid sequence that is unrelated to erythropoietin, a ...
Affymax Announces Results of Hematide Phase 2 Trial to be ... Dec 5, 2005
PharmaLive.com (press release), The poster presentation (ASH abstract #3532), entitled "Hematide, a Synthetic Peptide-Based Erythropoiesis-Stimulating Agent (ESA), Demonstrates Erythropoietic ...
|
|
